Eric Adler

CIK: 0001994972

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)6 (75.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (25.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

LXEO

Lexeo Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (8 total)

LXEO
Lexeo Therapeutics, Inc.
Nov 18, 2025
Sale(S)
Direct
615 shares at avg. $9.27$6K
LXEO
Lexeo Therapeutics, Inc.
Oct 17, 2025
Sale(S)
Direct
3.3K shares at avg. $8.94$30K
LXEO
Lexeo Therapeutics, Inc.
Oct 17, 2025
Sale(S)
Direct
38 shares at avg. $9.56$363.318
LXEO
Lexeo Therapeutics, Inc.
Oct 15, 2025
Award(A)
Direct
9.6K shares-
LXEO
Lexeo Therapeutics, Inc.
Aug 18, 2025
Sale(S)
Direct
608 shares at avg. $4.67$3K
LXEO
Lexeo Therapeutics, Inc.
May 16, 2025
Sale(S)
Direct
585 shares at avg. $2.77$2K
LXEO
Lexeo Therapeutics, Inc.
Feb 19, 2025
Sale(S)
Direct
2.4K shares at avg. $4.41$10K
LXEO
Lexeo Therapeutics, Inc.
Jan 7, 2025
Award(A)
Direct
43.8K shares-

		Type	Shares	Price		Ownership
Nov 18, 2025	LXEO Lexeo Therapeutics, Inc.	Sale(S)	615	$9.27	$5,701	Direct
Oct 17, 2025	LXEO Lexeo Therapeutics, Inc.	Sale(S)	3,344	$8.94	$29,879	Direct
Oct 17, 2025	LXEO Lexeo Therapeutics, Inc.	Sale(S)	38	$9.56	$363	Direct
Oct 15, 2025	LXEO Lexeo Therapeutics, Inc.	Award(A)	9,570	-	-	Direct
Aug 18, 2025	LXEO Lexeo Therapeutics, Inc.	Sale(S)	608	$4.67	$2,838	Direct
May 16, 2025	LXEO Lexeo Therapeutics, Inc.	Sale(S)	585	$2.77	$1,623	Direct
Feb 19, 2025	LXEO Lexeo Therapeutics, Inc.	Sale(S)	2,359	$4.41	$10,410	Direct
Jan 7, 2025	LXEO Lexeo Therapeutics, Inc.	Award(A)	43,750	-	$0	Direct

1-8 of 8 transactions

About Adler Eric

Adler Eric (SEC CIK 0001994972) files insider reports with the SEC as Chief Medical Officer of Lexeo Therapeutics, Inc. (LXEO).

Signal8 holds 6 ownership filings by Adler Eric, all Form 4s, filed between Jan 10, 2025 and Nov 20, 2025. Those filings report 8 transactions, from Jan 7, 2025 to Nov 18, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on Adler Eric's filings is in NEW YORK, NY.

Recent filings by Adler Eric

Nov 18, 2025: Open-market sale of LXEO shares (Form 4, code S).
Oct 17, 2025: Open-market sales of LXEO shares (2 lines, Form 4, code S).
Oct 15, 2025: Grant or award of LXEO shares (Form 4, code A).
Aug 18, 2025: Open-market sale of LXEO shares (Form 4, code S).
May 16, 2025: Open-market sale of LXEO shares (Form 4, code S).

Other insiders filing for Lexeo Therapeutics, Inc. (LXEO)

Tamayo Louis Edward, Chief Financial Officer
Bhalla Narinder Pal, Chief Medical Officer
Otero Jose Manuel, Chief Operating Officer
Townsend Richard Nolan, Chief Executive Officer
Altschuler Steven, Director
Agger Mette Kirstine, Director

How to read Form 4 transaction codes